Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
2.
Sci Rep ; 8(1): 2725, 2018 02 09.
Article de Anglais | MEDLINE | ID: mdl-29426942

RÉSUMÉ

Galectin-1 (Gal-1) is required for the development of B cells in the bone marrow (BM), however very little is known about the contribution of Gal-1 to the development of B cell regulatory function. Here, we report an important role for Gal-1 in the induction of B cells regulatory function. Mice deficient of Gal-1 (Gal-1-/-) showed significant loss of Transitional-2 (T2) B cells, previously reported to include IL-10+ regulatory B cells. Gal-1-/- B cells stimulated in vitro via CD40 molecules have impaired IL-10 and Tim-1 expression, the latter reported to be required for IL-10 production in regulatory B cells, and increased TNF-α expression compared to wild type (WT) B cells. Unlike their WT counterparts, T2 and T1 Gal-1-/- B cells did not suppress TNF-α expression by CD4+ T cells activated in vitro with allogenic DCs (allo-DCs), nor were they suppressive in vivo, being unable to delay MHC-class I mismatched skin allograft rejection following adoptive transfer. Moreover, T cells stimulated with allo-DCs show an increase in their survival when co-cultured with Gal-1-/- T2 and MZ B cells compared to WT T2 and MZ B cells. Collectively, these data suggest that Gal-1 contributes to the induction of B cells regulatory function.


Sujet(s)
Lymphocytes B régulateurs/immunologie , Cellules dendritiques/immunologie , Galectine 1/physiologie , Survie du greffon , Activation des lymphocytes , Allogreffes , Animaux , Lymphocytes B régulateurs/métabolisme , Lymphocytes B régulateurs/anatomopathologie , Cellules dendritiques/métabolisme , Cellules dendritiques/anatomopathologie , Interleukine-10/métabolisme , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris knockout , Transplantation de peau , Lymphocytes T/immunologie , Lymphocytes T/métabolisme , Lymphocytes T/anatomopathologie , Facteur de nécrose tumorale alpha/métabolisme
3.
Sci Rep ; 5: 11554, 2015 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-26109230

RÉSUMÉ

B cells have been reported to promote graft rejection through alloantibody production. However, there is growing evidence that B cells can contribute to the maintenance of tolerance. Here, we used a mouse model of MHC-class I mismatched skin transplantation to investigate the contribution of B cells to graft survival. We demonstrate that adoptive transfer of B cells prolongs skin graft survival but only when the B cells were isolated from mice housed in low sterility "conventional" (CV) facilities and not from mice housed in pathogen free facilities (SPF). However, prolongation of skin graft survival was lost when B cells were isolated from IL-10 deficient mice housed in CV facilities. The suppressive function of B cells isolated from mice housed in CV facilities correlated with an anti-inflammatory environment and with the presence of a different gut microflora compared to mice maintained in SPF facilities. Treatment of mice in the CV facility with antibiotics abrogated the regulatory capacity of B cells. Finally, we identified transitional B cells isolated from CV facilities as possessing the regulatory function. These findings demonstrate that B cells, and in particular transitional B cells, can promote prolongation of graft survival, a function dependent on licensing by gut microflora.


Sujet(s)
Lymphocytes B/immunologie , Microbiome gastro-intestinal , Transplantation de peau , Immunité acquise , Transfert adoptif , Animaux , Antibactériens/pharmacologie , Lymphocytes B/cytologie , Lymphocytes B/enzymologie , Cytokines/métabolisme , Modèles animaux de maladie humaine , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Survie du greffon/immunologie , Antigènes d'histocompatibilité de classe I/génétique , Antigènes d'histocompatibilité de classe I/métabolisme , Tolérance immunitaire , Interleukine-10/déficit , Interleukine-10/génétique , Lipopolysaccharides/toxicité , Noeuds lymphatiques/immunologie , Noeuds lymphatiques/anatomopathologie , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris knockout , Rate/immunologie , Rate/anatomopathologie , Transplantation homologue
4.
Am J Transplant ; 11(8): 1610-20, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21797973

RÉSUMÉ

CD4(+) CD25(+) regulatory T cells (T(reg) cells) are an attractive adoptive cell therapy in mediating transplantation tolerance. T-cell receptor (TcR) activation is critical for T(reg) function, suggesting that the TcR avidity of T(reg) cells used in therapy may affect the therapeutic outcome. To address this, we compared the regulatory capacity of T(reg) lines expressing TcRs derived from two TcR transgenic mice shown to have the same specificity but different functional avidities. T(reg) lines generated from CD4(+)CD25(+) T cells from C57BL/6 mice were transduced with one of either of these TcRs. The antigen specificity of the transduced T(reg) lines was confirmed in vitro. T(reg) lines expressing the TcR with higher functional avidity showed stronger suppressive capacity in a linked suppression model in vitro. Furthermore, the same T(reg) lines demonstrated a stronger proliferation in vivo following antigen exposure. Pretreatment of recipient BL/6 mice with these T(reg) cells, together with anti-CD8 antibody and Rapamycin therapies, prolonged survival of BALB/c skins, as compared with mice that received T(reg) lines with lower TcR avidity. Taken together, these data suggest that the TcR functional avidity may be important for T(reg) function. It highlights the fact that strategies to select T(reg) with higher functional avidity might be beneficial for immunotherapy in transplantation.


Sujet(s)
Lymphocytes T régulateurs/immunologie , Animaux , Séquence nucléotidique , Amorces ADN , Cytométrie en flux , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris transgéniques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE